Startup Dossier
EVerZom
French biotechnology company pioneering exosome-based biotherapies for regenerative medicine and inflammatory diseases. EVerZom is developing first-in-class therapeutics leveraging mesenchymal stem cell-derived exosomes, combined with biomaterials, to treat complex diseases with high unmet medical need.
active
Typestartup
SectorBioTech
LocationStrasbourg
About
French biotechnology company pioneering exosome-based biotherapies for regenerative medicine and inflammatory diseases. EVerZom is developing first-in-class therapeutics leveraging mesenchymal stem cell-derived exosomes, combined with biomaterials, to treat complex diseases with high unmet medical need.
Structural DNA
Legal Name
EVerZom
SIREN
854006681
Founders & Team
Funding Lineage
Series A
European Innovation Council (Lead)
€10.0M
Oct 2025
Programs
i-Lab
2019Pharmacie & biotechnologies